CRBP Corbus Pharmaceuticals | $41.62 -4.7% | 3/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $51.00 -> $58.00 | Low | View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 3/13/2024 |
CRNX Crinetics Pharmaceuticals | $37.93 -2.6% | 3/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $54.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/13/2024 |
DRI Darden Restaurants | $172.87 +0.5% | 3/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $186.00 | Low | View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 3/13/2024 |
RRX Regal Rexnord | $173.43 +0.4% | 3/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $210.00 | Low | View details for Oppenheimer rating of Regal Rexnord (NYSE:RRX) on 3/13/2024 |
TRMB Trimble | $62.45 +0.6% | 3/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $72.00 | Low | View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 3/14/2024 |
ADBE Adobe | $513.86 +4.3% | 3/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $660.00 | N/A | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 3/15/2024 |
|
LEN Lennar | $156.61 +0.0% | 3/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Lennar (NYSE:LEN) on 3/15/2024 |
MDGL Madrigal Pharmaceuticals | $283.23 +4.8% | 3/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $320.00 -> $375.00 | N/A | View details for Oppenheimer rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 3/15/2024 |
PTMN Portman Ridge Finance | $19.17 +0.4% | 3/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $20.00 | N/A | View details for Oppenheimer rating of Portman Ridge Finance (NASDAQ:PTMN) on 3/15/2024 |
SEIC SEI Investments | $68.74 +0.2% | 3/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $73.00 -> $77.00 | N/A | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 3/15/2024 |
SMAR Smartsheet | $38.65 +3.0% | 3/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $55.00 | N/A | View details for Oppenheimer rating of Smartsheet (NYSE:SMAR) on 3/15/2024 |
URGN UroGen Pharma | $14.50 +0.3% | 3/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $35.00 -> $34.00 | N/A | View details for Oppenheimer rating of UroGen Pharma (NASDAQ:URGN) on 3/15/2024 |
WSM Williams-Sonoma | $285.42 +0.6% | 3/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Williams-Sonoma (NYSE:WSM) on 3/15/2024 |
EW Edwards Lifesciences | $92.86 +0.6% | 3/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $93.00 -> $100.00 | Low | View details for Oppenheimer rating of Edwards Lifesciences (NYSE:EW) on 3/18/2024 |
WCN Waste Connections | $171.72 +0.5% | 3/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $170.00 -> $180.00 | Low | View details for Oppenheimer rating of Waste Connections (NYSE:WCN) on 3/18/2024 |
VTYX Ventyx Biosciences | $7.98 +3.6% | 3/12/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $12.00 | Low | View details for Oppenheimer rating of Ventyx Biosciences (NASDAQ:VTYX) on 3/12/2024 |
NFLX Netflix | $618.39 +2.1% | 3/11/2024 | Target Raised by | Oppenheimer | - | Outperform | $615.00 -> $725.00 | Low | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 3/11/2024 |
RWAY Runway Growth Finance | $11.75 -0.6% | 3/8/2024 | Reiterated by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Runway Growth Finance (NASDAQ:RWAY) on 3/8/2024 |
FIGS FIGS | $4.95 -1.6% | 3/8/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of FIGS (NYSE:FIGS) on 3/8/2024 |
FROG JFrog | $43.11 +2.2% | 3/7/2024 | Target Raised by | Oppenheimer | - | | $41.00 -> $48.00 | Low | View details for Oppenheimer rating of JFrog (NASDAQ:FROG) on 3/7/2024 |
EHAB Enhabit | $10.96 -0.5% | 3/7/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Enhabit (NYSE:EHAB) on 3/7/2024 |
JSPR Jasper Therapeutics | $24.86 -0.9% | 3/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $80.00 | Low | View details for Oppenheimer rating of Jasper Therapeutics (NASDAQ:JSPR) on 3/7/2024 |
MRNS Marinus Pharmaceuticals | $9.02 -3.9% | 3/7/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $9.00 | Low | View details for Oppenheimer rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 3/7/2024 |
PNR Pentair | $80.64 +0.0% | 3/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $82.00 -> $88.00 | Low | View details for Oppenheimer rating of Pentair (NYSE:PNR) on 3/7/2024 |
RSI Rush Street Interactive | $5.90 +1.7% | 3/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $9.00 | Low | View details for Oppenheimer rating of Rush Street Interactive (NYSE:RSI) on 3/7/2024 |
WCC WESCO International | $161.93 +1.1% | 3/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $175.00 -> $190.00 | N/A | View details for Oppenheimer rating of WESCO International (NYSE:WCC) on 3/7/2024 |
AOMR Angel Oak Mortgage REIT | $10.60 +0.7% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Angel Oak Mortgage REIT (NYSE:AOMR) on 3/6/2024 |
CNNE Cannae | $21.90 -0.3% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $27.00 | Low | View details for Oppenheimer rating of Cannae (NYSE:CNNE) on 3/6/2024 |
CHPT ChargePoint | $1.73 +3.0% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of ChargePoint (NYSE:CHPT) on 3/6/2024 |
BASE Couchbase | $27.03 -0.6% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $36.00 | Low | View details for Oppenheimer rating of Couchbase (NASDAQ:BASE) on 3/6/2024 |
CRWD CrowdStrike | $321.06 +1.7% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $355.00 | N/A | View details for Oppenheimer rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
DG Dollar General | $155.76 +2.5% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Dollar General (NYSE:DG) on 3/6/2024 |
HCP HashiCorp | $28.64 +8.1% | 3/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $34.00 | Low | View details for Oppenheimer rating of HashiCorp (NASDAQ:HCP) on 3/6/2024 |
IONS Ionis Pharmaceuticals | $42.03 -1.2% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $72.00 | Low | View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 3/6/2024 |
MCRB Seres Therapeutics | $0.76 -3.8% | 3/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $9.00 -> $5.00 | Low | View details for Oppenheimer rating of Seres Therapeutics (NASDAQ:MCRB) on 3/6/2024 |
SCM Stellus Capital Investment | $13.07 -0.2% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $14.00 | Low | View details for Oppenheimer rating of Stellus Capital Investment (NYSE:SCM) on 3/6/2024 |
SYF Synchrony Financial | $41.75 -0.1% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Synchrony Financial (NYSE:SYF) on 3/6/2024 |
AEVA Aeva Technologies | $1.01 +2.0% | 3/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $5.00 | Low | View details for Oppenheimer rating of Aeva Technologies (NYSE:AEVA) on 3/6/2024 |
ETNB 89bio | $12.60 -6.8% | 3/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of 89bio (NASDAQ:ETNB) on 3/5/2024 |
CODI Compass Diversified | $23.29 -1.1% | 3/5/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $21.00 -> $23.00 | Low | View details for Oppenheimer rating of Compass Diversified (NYSE:CODI) on 3/5/2024 |
Like Tiny Crypto Retirement Funds (Ad) The crypto bull market is about to blast off.
Bitcoin and Ethereum are surging.
But so are tiny altcoins that could be so profitable…
They're like tiny crypto retirement funds.
Click here and see how to get a copy. |
COST Costco Wholesale | $731.54 +0.8% | 3/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $760.00 -> $805.00 | Low | View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 3/5/2024 |
DYN Dyne Therapeutics | $26.28 -6.1% | 3/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $44.00 -> $47.00 | Low | View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 3/5/2024 |
GE General Electric | $169.91 +0.6% | 3/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of General Electric (NYSE:GE) on 3/5/2024 |
IMRX Immuneering | $2.56 +34.0% | 3/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $25.00 | Low | View details for Oppenheimer rating of Immuneering (NASDAQ:IMRX) on 3/5/2024 |
GWW W.W. Grainger | $994.49 +0.0% | 3/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $1,075.00 -> $1,125.00 | Low | View details for Oppenheimer rating of W.W. Grainger (NYSE:GWW) on 3/5/2024 |
AVDL Avadel Pharmaceuticals | $15.77 -0.9% | 3/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $27.00 -> $29.00 | Low | View details for Oppenheimer rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 3/5/2024 |
DLTR Dollar Tree | $127.25 -0.1% | 3/4/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Dollar Tree (NASDAQ:DLTR) on 3/4/2024 |
CYTK Cytokinetics | $63.75 -2.2% | 3/4/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $107.00 | Low | View details for Oppenheimer rating of Cytokinetics (NASDAQ:CYTK) on 3/4/2024 |
LOW Lowe's Companies | $243.48 -0.5% | 3/4/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $230.00 | Low | View details for Oppenheimer rating of Lowe’s Companies (NYSE:LOW) on 3/4/2024 |
MDGL Madrigal Pharmaceuticals | $283.23 +4.8% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $320.00 | Low | View details for Oppenheimer rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 3/1/2024 |
SG Sweetgreen | $22.08 -0.5% | 3/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 -> $17.00 | Low | View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 3/1/2024 |
PNTG The Pennant Group | $18.95 +3.0% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $18.00 -> $22.00 | Low | View details for Oppenheimer rating of The Pennant Group (NASDAQ:PNTG) on 3/1/2024 |
ADSK Autodesk | $255.18 +0.4% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $265.00 -> $315.00 | Low | View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 3/1/2024 |
AVGO Broadcom | $1,237.24 +0.1% | 3/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $1,100.00 -> $1,500.00 | Low | View details for Oppenheimer rating of Broadcom (NASDAQ:AVGO) on 3/1/2024 |
ESTC Elastic | $101.62 +0.5% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $130.00 | Low | View details for Oppenheimer rating of Elastic (NYSE:ESTC) on 3/1/2024 |
HRZN Horizon Technology Finance | $11.35 -2.6% | 3/1/2024 | Target Lowered by | Oppenheimer | - | Market Perform -> Market Perform | $11.00 -> $10.00 | Low | View details for Oppenheimer rating of Horizon Technology Finance (NASDAQ:HRZN) on 3/1/2024 |
EVH Evolent Health | $32.17 -1.5% | 3/1/2024 | Initiated by | Oppenheimer | - | Outperform | $45.00 | N/A | View details for Oppenheimer rating of Evolent Health (NYSE:EVH) on 3/1/2024 |
TBLA Taboola.com | $4.33 +4.3% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $5.50 -> $6.00 | Low | View details for Oppenheimer rating of Taboola.com (NASDAQ:TBLA) on 2/29/2024 |
CHE Chemed | $648.15 +0.2% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $625.00 -> $650.00 | Low | View details for Oppenheimer rating of Chemed (NYSE:CHE) on 2/29/2024 |
CRNX Crinetics Pharmaceuticals | $37.93 -2.6% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $46.00 -> $48.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 2/29/2024 |
IMCR Immunocore | $60.49 -0.6% | 2/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $87.00 | Low | View details for Oppenheimer rating of Immunocore (NASDAQ:IMCR) on 2/29/2024 |
MRVL Marvell Technology | $67.20 +0.5% | 2/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $80.00 | Low | View details for Oppenheimer rating of Marvell Technology (NASDAQ:MRVL) on 2/29/2024 |
MMSI Merit Medical Systems | $72.20 +0.5% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $82.00 -> $87.00 | Low | View details for Oppenheimer rating of Merit Medical Systems (NASDAQ:MMSI) on 2/29/2024 |
OKTA Okta | $105.88 -0.2% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $125.00 | Low | View details for Oppenheimer rating of Okta (NASDAQ:OKTA) on 2/29/2024 |
RLJ RLJ Lodging Trust | $11.86 +0.9% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $15.00 | Low | View details for Oppenheimer rating of RLJ Lodging Trust (NYSE:RLJ) on 2/29/2024 |
RXST RxSight | $46.76 -0.9% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $54.00 -> $61.00 | Low | View details for Oppenheimer rating of RxSight (NASDAQ:RXST) on 2/29/2024 |
SHLS Shoals Technologies Group | $11.71 -2.9% | 2/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $42.00 -> $17.00 | Low | View details for Oppenheimer rating of Shoals Technologies Group (NASDAQ:SHLS) on 2/29/2024 |
SNOW Snowflake | $156.31 -0.4% | 2/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $240.00 -> $220.00 | Low | View details for Oppenheimer rating of Snowflake (NYSE:SNOW) on 2/29/2024 |
ARVN Arvinas | $42.60 -5.0% | 2/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $80.00 | Low | View details for Oppenheimer rating of Arvinas (NASDAQ:ARVN) on 2/28/2024 |
CLVT Clarivate | $7.21 +2.1% | 2/28/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $10.00 | Low | View details for Oppenheimer rating of Clarivate (NYSE:CLVT) on 2/28/2024 |
COMP Compass | $3.06 +4.1% | 2/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $5.50 -> $6.00 | Low | View details for Oppenheimer rating of Compass (NYSE:COMP) on 2/28/2024 |
FSLR First Solar | $149.48 +1.4% | 2/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $268.00 -> $269.00 | Low | View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 2/28/2024 |
IAS Integral Ad Science | $9.58 +2.2% | 2/28/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $20.00 | Low | View details for Oppenheimer rating of Integral Ad Science (NASDAQ:IAS) on 2/28/2024 |
QUIK QuickLogic | $19.14 +8.7% | 2/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $16.00 | Low | View details for Oppenheimer rating of QuickLogic (NASDAQ:QUIK) on 2/28/2024 |
RSG Republic Services | $187.57 +0.7% | 2/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $182.00 -> $195.00 | Low | View details for Oppenheimer rating of Republic Services (NYSE:RSG) on 2/28/2024 |
TARS Tarsus Pharmaceuticals | $30.61 -3.1% | 2/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $59.00 | Low | View details for Oppenheimer rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 2/28/2024 |
VKTX Viking Therapeutics | $63.35 +1.3% | 2/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $46.00 -> $116.00 | Low | View details for Oppenheimer rating of Viking Therapeutics (NASDAQ:VKTX) on 2/28/2024 |
WMT Walmart | $60.86 +0.3% | 2/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $67.00 | Low | View details for Oppenheimer rating of Walmart (NYSE:WMT) on 2/26/2024 |
CARG CarGurus | $23.46 +4.4% | 2/27/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $26.00 -> $30.00 | Low | View details for Oppenheimer rating of CarGurus (NASDAQ:CARG) on 2/27/2024 |
DAWN Day One Biopharmaceuticals | $13.93 -3.2% | 2/27/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 2/27/2024 |
FATE Fate Therapeutics | $7.04 -6.0% | 2/27/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Fate Therapeutics (NASDAQ:FATE) on 2/27/2024 |
TMDX TransMedics Group | $74.16 -2.3% | 2/27/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $92.00 -> $105.00 | Low | View details for Oppenheimer rating of TransMedics Group (NASDAQ:TMDX) on 2/27/2024 |
IONS Ionis Pharmaceuticals | $42.03 -1.2% | 2/26/2024 | Reiterated by | Oppenheimer | - | Outperform | $63.00 -> $65.00 | Low | View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 2/26/2024 |
MAIN Main Street Capital | $46.02 -0.4% | 2/26/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $41.00 -> $43.00 | Low | View details for Oppenheimer rating of Main Street Capital (NYSE:MAIN) on 2/26/2024 |
POOL Pool | $397.30 -0.5% | 2/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $370.00 -> $407.00 | Low | View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 2/26/2024 |
SONY Sony Group | $89.04 +1.9% | 2/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $108.00 | Low | View details for Oppenheimer rating of Sony Group (NYSE:SONY) on 2/26/2024 |
TGT Target | $167.61 +2.1% | 2/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $160.00 -> $170.00 | Low | View details for Oppenheimer rating of Target (NYSE:TGT) on 2/26/2024 |
NICE NICE | $238.84 +0.4% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $225.00 -> $300.00 | Low | View details for Oppenheimer rating of NICE (NASDAQ:NICE) on 2/23/2024 |
OLED Universal Display | $159.51 -0.1% | 2/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $210.00 -> $200.00 | Low | View details for Oppenheimer rating of Universal Display (NASDAQ:OLED) on 2/23/2024 |
SPXC SPX Technologies | $116.77 -0.1% | 2/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $118.00 -> $124.00 | Low | View details for Oppenheimer rating of SPX Technologies (NYSE:SPXC) on 2/23/2024 |
Make This $3 Trade the Instant the Opening Bell Rings (Ad) Since the birth of Wall Street, one simple rule has remained the same....
Buy stocks that are cheap....When they’re on sale….
And when nobody else is looking… See Why This $3.00 Stock Could Hit $15.00 |
TOL Toll Brothers | $119.61 -0.6% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $141.00 | Low | View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 2/23/2024 |
ACA Arcosa | $80.72 -1.1% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $90.00 | Low | View details for Oppenheimer rating of Arcosa (NYSE:ACA) on 2/23/2024 |
ALTR Altair Engineering | $80.28 +1.6% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $100.00 | Low | View details for Oppenheimer rating of Altair Engineering (NASDAQ:ALTR) on 2/23/2024 |
BLDR Builders FirstSource | $195.44 0.0% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $220.00 -> $242.00 | Low | View details for Oppenheimer rating of Builders FirstSource (NYSE:BLDR) on 2/23/2024 |
CCAP Crescent Capital BDC | $17.20
| 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $18.00 -> $19.00 | Low | View details for Oppenheimer rating of Crescent Capital BDC (NASDAQ:CCAP) on 2/23/2024 |
INTU Intuit | $630.39 +0.8% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $678.00 -> $712.00 | Low | View details for Oppenheimer rating of Intuit (NASDAQ:INTU) on 2/23/2024 |
CYH Community Health Systems | $2.95 +6.1% | 2/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $6.50 -> $5.50 | Low | View details for Oppenheimer rating of Community Health Systems (NYSE:CYH) on 2/22/2024 |
DOCN DigitalOcean | $40.56 +3.7% | 2/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $37.00 -> $46.00 | Low | View details for Oppenheimer rating of DigitalOcean (NASDAQ:DOCN) on 2/22/2024 |
NVDA NVIDIA | $884.55 +0.7% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $850.00 | Low | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 2/22/2024 |
ADI Analog Devices | $191.22 -2.0% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $215.00 | Low | View details for Oppenheimer rating of Analog Devices (NASDAQ:ADI) on 2/22/2024 |
JACK Jack in the Box | $71.91 -2.0% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $98.00 | Low | View details for Oppenheimer rating of Jack in the Box (NASDAQ:JACK) on 2/22/2024 |
PNST Pinstripes | $4.12 +2.7% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $6.00 | Low | View details for Oppenheimer rating of Pinstripes (NYSE:PNST) on 2/22/2024 |
CAKE Cheesecake Factory | $35.65 -0.3% | 2/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Cheesecake Factory (NASDAQ:CAKE) on 2/22/2024 |
RUN Sunrun | $10.26 +3.7% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $19.00 | Low | View details for Oppenheimer rating of Sunrun (NASDAQ:RUN) on 2/22/2024 |
CNNE Cannae | $21.90 -0.3% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $25.00 | Low | View details for Oppenheimer rating of Cannae (NYSE:CNNE) on 2/22/2024 |
ADSK Autodesk | $255.18 +0.4% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $265.00 | Low | View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 2/22/2024 |
GWRE Guidewire Software | $113.54 +0.8% | 2/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $115.00 -> $130.00 | Low | View details for Oppenheimer rating of Guidewire Software (NYSE:GWRE) on 2/22/2024 |
VEEV Veeva Systems | $228.45 +0.6% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $225.00 | Low | View details for Oppenheimer rating of Veeva Systems (NYSE:VEEV) on 2/22/2024 |
SKIL Skillsoft | $8.45 -9.7% | 2/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Skillsoft (NASDAQ:SKIL) on 2/22/2024 |
CLH Clean Harbors | $191.20 +1.8% | 2/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $178.00 -> $200.00 | Low | View details for Oppenheimer rating of Clean Harbors (NYSE:CLH) on 2/22/2024 |
DPZ Domino's Pizza | $442.86 +0.4% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $470.00 | Low | View details for Oppenheimer rating of Domino’s Pizza (NYSE:DPZ) on 2/22/2024 |
NVRO Nevro | $14.10 +2.7% | 2/22/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Nevro (NYSE:NVRO) on 2/22/2024 |
VTYX Ventyx Biosciences | $7.98 +3.6% | 2/21/2024 | Reiterated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Ventyx Biosciences (NASDAQ:VTYX) on 2/21/2024 |
LYV Live Nation Entertainment | $104.38 +0.6% | 2/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $105.00 -> $115.00 | Low | View details for Oppenheimer rating of Live Nation Entertainment (NYSE:LYV) on 2/21/2024 |
MDT Medtronic | $83.67 +0.1% | 2/21/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $89.00 -> $92.00 | Low | View details for Oppenheimer rating of Medtronic (NYSE:MDT) on 2/21/2024 |
PANW Palo Alto Networks | $285.24 +1.1% | 2/21/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $310.00 -> $305.00 | Low | View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 2/21/2024 |
TPH Tri Pointe Homes | $34.19 -0.1% | 2/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $41.00 | Low | View details for Oppenheimer rating of Tri Pointe Homes (NYSE:TPH) on 2/21/2024 |
B Barnes Group | $36.45 -0.3% | 2/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $43.00 | Low | View details for Oppenheimer rating of Barnes Group (NYSE:B) on 2/20/2024 |
DKNG DraftKings | $43.52 +4.2% | 2/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $60.00 | Low | View details for Oppenheimer rating of DraftKings (NASDAQ:DKNG) on 2/20/2024 |
PRTA Prothena | $25.09 -3.8% | 2/20/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $98.00 -> $80.00 | Low | View details for Oppenheimer rating of Prothena (NASDAQ:PRTA) on 2/20/2024 |
ALB Albemarle | $124.58 +2.0% | 2/16/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $191.00 -> $188.00 | Low | View details for Oppenheimer rating of Albemarle (NYSE:ALB) on 2/16/2024 |
BLZE Backblaze | $10.37 +3.3% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $7.50 -> $11.00 | Low | View details for Oppenheimer rating of Backblaze (NASDAQ:BLZE) on 2/16/2024 |
COIN Coinbase Global | $239.62 -1.1% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $160.00 -> $200.00 | Low | View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 2/16/2024 |
DASH DoorDash | $129.58 -0.7% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $140.00 | Low | View details for Oppenheimer rating of DoorDash (NASDAQ:DASH) on 2/16/2024 |
FRPT Freshpet | $108.41 -1.0% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $100.00 -> $115.00 | Low | View details for Oppenheimer rating of Freshpet (NASDAQ:FRPT) on 2/16/2024 |
NVDA NVIDIA | $884.55 +0.7% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $650.00 -> $850.00 | Low | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 2/16/2024 |
SCI Service Co. International | $72.50 +0.0% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $71.00 -> $76.00 | Low | View details for Oppenheimer rating of Service Co. International (NYSE:SCI) on 2/16/2024 |
SHAK Shake Shack | $104.79 +1.1% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $80.00 -> $108.00 | Low | View details for Oppenheimer rating of Shake Shack (NYSE:SHAK) on 2/16/2024 |
TTD Trade Desk | $78.35 +2.1% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $105.00 | Low | View details for Oppenheimer rating of Trade Desk (NASDAQ:TTD) on 2/16/2024 |
ROKU Roku | $63.37 -1.0% | 2/16/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Roku (NASDAQ:ROKU) on 2/16/2024 |
NKE NIKE | $98.74 -0.9% | 2/16/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | $110.00 | Low | View details for Oppenheimer rating of NIKE (NYSE:NKE) on 2/16/2024 |
BIIB Biogen | $219.40 +0.0% | 2/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $295.00 -> $290.00 | Low | View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 2/14/2024 |
BOWL Bowlero | $12.90
| 2/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $16.00 -> $18.00 | Low | View details for Oppenheimer rating of Bowlero (NYSE:BOWL) on 2/14/2024 |
DENN Denny's | $8.80 -1.3% | 2/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $13.00 -> $12.00 | Low | View details for Oppenheimer rating of Denny’s (NASDAQ:DENN) on 2/14/2024 |
GCMG Grosvenor Capital Management | $8.80 -1.3% | 2/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $13.00 -> $12.00 | Low | View details for Oppenheimer rating of Grosvenor Capital Management (NASDAQ:GCMG) on 2/14/2024 |
MCO Moody's | $384.08 0.0% | 2/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $427.00 -> $411.00 | Low | View details for Oppenheimer rating of Moody’s (NYSE:MCO) on 2/14/2024 |
WCC WESCO International | $161.93 +1.1% | 2/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $175.00 | Low | View details for Oppenheimer rating of WESCO International (NYSE:WCC) on 2/14/2024 |
WM Waste Management | $211.67 +0.5% | 2/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $188.00 -> $212.00 | Low | View details for Oppenheimer rating of Waste Management (NYSE:WM) on 2/14/2024 |
XPO XPO | $122.04 -0.5% | 2/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $100.00 -> $130.00 | Low | View details for Oppenheimer rating of XPO (NYSE:XPO) on 2/14/2024 |
ANET Arista Networks | $289.32 +4.2% | 2/13/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Arista Networks (NYSE:ANET) on 2/13/2024 |
AI Cracks Open Largest Untapped Energy Reserve on Earth (Ad) This orb represents the largest untapped energy source in the world…
And although this energy resource is unknown by 99% of the public…
It makes gas, coal, oil, wind, hydropower, solar, fusion… ]click here to watch a free presentation where I reveal all the details of this lucrative opportunit |
MNDY monday.com | $223.22 +2.9% | 2/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $220.00 -> $240.00 | Low | View details for Oppenheimer rating of monday.com (NASDAQ:MNDY) on 2/13/2024 |
RXO RXO | $19.74 -0.7% | 2/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $23.00 -> $22.00 | Low | View details for Oppenheimer rating of RXO (NYSE:RXO) on 2/13/2024 |
TRMB Trimble | $62.45 +0.6% | 2/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $59.00 -> $65.00 | Low | View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 2/13/2024 |
DKNG DraftKings | $43.52 +4.2% | 2/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $44.00 -> $55.00 | Low | View details for Oppenheimer rating of DraftKings (NASDAQ:DKNG) on 2/13/2024 |
GILD Gilead Sciences | $73.26 -0.6% | 2/12/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $115.00 -> $105.00 | Low | View details for Oppenheimer rating of Gilead Sciences (NASDAQ:GILD) on 2/12/2024 |
CRM Salesforce | $300.51 +2.1% | 2/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $325.00 | Low | View details for Oppenheimer rating of Salesforce (NYSE:CRM) on 2/12/2024 |
WMT Walmart | $60.86 +0.3% | 2/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $58.33 -> $61.67 | Low | View details for Oppenheimer rating of Walmart (NYSE:WMT) on 2/12/2024 |
PSBD Palmer Square Capital BDC | $16.57 +0.9% | 2/12/2024 | Initiated by | Oppenheimer | - | Outperform | $17.00 | Low | View details for Oppenheimer rating of Palmer Square Capital BDC (NYSE:PSBD) on 2/12/2024 |
BILL BILL | $67.47 +4.4% | 2/9/2024 | Target Raised by | Oppenheimer | - | Overweight -> Overweight | $75.00 -> $83.00 | Low | View details for Oppenheimer rating of BILL (NYSE:BILL) on 2/9/2024 |
ENS EnerSys | $89.72 -1.6% | 2/9/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of EnerSys (NYSE:ENS) on 2/9/2024 |
FUN Cedar Fair | $42.96 -0.1% | 2/8/2024 | Initiated by | Oppenheimer | - | Outperform | $49.00 | Low | View details for Oppenheimer rating of Cedar Fair (NYSE:FUN) on 2/8/2024 |
ENPH Enphase Energy | $111.19 +3.2% | 2/7/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $133.00 | Low | View details for Oppenheimer rating of Enphase Energy (NASDAQ:ENPH) on 2/7/2024 |
CHD Church & Dwight | $104.26 -0.1% | 2/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $107.00 -> $110.00 | Low | View details for Oppenheimer rating of Church & Dwight (NYSE:CHD) on 2/5/2024 |
EXPE Expedia Group | $133.21 -0.2% | 2/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $175.00 | Low | View details for Oppenheimer rating of Expedia Group (NASDAQ:EXPE) on 2/5/2024 |
WT WisdomTree | $8.88 -0.6% | 2/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $12.00 | Low | View details for Oppenheimer rating of WisdomTree (NYSE:WT) on 2/5/2024 |
ACAD ACADIA Pharmaceuticals | $18.72 +1.3% | 2/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $25.00 | Low | View details for Oppenheimer rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 2/5/2024 |
BKNG Booking | $3,450.93 +1.1% | 2/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $3,450.00 -> $4,200.00 | Low | View details for Oppenheimer rating of Booking (NASDAQ:BKNG) on 2/5/2024 |
AAPL Apple | $173.72 +0.6% | 2/2/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $200.00 | Low | View details for Oppenheimer rating of Apple (NASDAQ:AAPL) on 2/2/2024 |
CTVA Corteva | $54.71 -0.7% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $62.00 | Low | View details for Oppenheimer rating of Corteva (NYSE:CTVA) on 2/2/2024 |
COST Costco Wholesale | $731.54 +0.8% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $695.00 -> $760.00 | Low | View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 2/2/2024 |
DOV Dover | $174.42 -0.6% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $175.00 -> $177.00 | Low | View details for Oppenheimer rating of Dover (NYSE:DOV) on 2/2/2024 |
THG The Hanover Insurance Group | $126.17 -2.2% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $135.00 -> $150.00 | Low | View details for Oppenheimer rating of The Hanover Insurance Group (NYSE:THG) on 2/2/2024 |
MPWR Monolithic Power Systems | $674.30 -1.8% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $600.00 -> $700.00 | Low | View details for Oppenheimer rating of Monolithic Power Systems (NASDAQ:MPWR) on 2/2/2024 |
ENSG The Ensign Group | $122.19 -0.4% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $127.00 -> $130.00 | Low | View details for Oppenheimer rating of The Ensign Group (NASDAQ:ENSG) on 2/2/2024 |
META Meta Platforms | $496.98 +2.7% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $385.00 -> $525.00 | Low | View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 2/2/2024 |
AMZN Amazon.com | $174.48 +0.0% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $210.00 | Low | View details for Oppenheimer rating of Amazon.com (NASDAQ:AMZN) on 2/2/2024 |
PTC PTC | $183.66 +1.0% | 2/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $190.00 -> $210.00 | Low | View details for Oppenheimer rating of PTC (NASDAQ:PTC) on 2/1/2024 |
SEIC SEI Investments | $68.74 +0.2% | 2/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $71.00 -> $73.00 | Low | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 2/1/2024 |
ROP Roper Technologies | $546.16 -0.2% | 2/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $580.00 | Low | View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 2/1/2024 |
NDAQ Nasdaq | $60.29 +1.0% | 2/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $68.00 | Low | View details for Oppenheimer rating of Nasdaq (NASDAQ:NDAQ) on 2/1/2024 |
NXPI NXP Semiconductors | $236.62 -0.4% | 2/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $220.00 -> $250.00 | Low | View details for Oppenheimer rating of NXP Semiconductors (NASDAQ:NXPI) on 2/1/2024 |
MA Mastercard | $479.07 +0.7% | 2/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $510.00 | Low | View details for Oppenheimer rating of Mastercard (NYSE:MA) on 2/1/2024 |
BSX Boston Scientific | $67.24 +1.5% | 2/1/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $58.00 -> $68.00 | Low | View details for Oppenheimer rating of Boston Scientific (NYSE:BSX) on 2/1/2024 |
APTV Aptiv | $77.81 +0.7% | 2/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $149.00 -> $148.00 | Low | View details for Oppenheimer rating of Aptiv (NYSE:APTV) on 2/1/2024 |
AMGN Amgen | $270.90 +0.8% | 2/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $350.00 | Low | View details for Oppenheimer rating of Amgen (NASDAQ:AMGN) on 2/1/2024 |
ROK Rockwell Automation | $278.17 -1.0% | 2/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $324.00 -> $300.00 | Low | View details for Oppenheimer rating of Rockwell Automation (NYSE:ROK) on 2/1/2024 |
BIIB Biogen | $219.40 +0.0% | 1/30/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $295.00 | Low | View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 1/30/2024 |
C Citigroup | $58.63 +1.8% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $93.00 -> $95.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 1/30/2024 |
GS The Goldman Sachs Group | $384.37 -0.7% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $491.00 -> $506.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 1/30/2024 |
JPM JPMorgan Chase & Co. | $192.70 +1.3% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $232.00 -> $238.00 | Low | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 1/30/2024 |
MS Morgan Stanley | $87.99 -0.4% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $106.00 -> $109.00 | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 1/30/2024 |
RMD ResMed | $191.05 +0.5% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $205.00 | Low | View details for Oppenheimer rating of ResMed (NYSE:RMD) on 1/30/2024 |
USB U.S. Bancorp | $42.48 +1.0% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $59.00 -> $61.00 | Low | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 1/30/2024 |
APLS Apellis Pharmaceuticals | $56.26 -0.8% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $75.00 -> $79.00 | Low | View details for Oppenheimer rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 1/30/2024 |
BAC Bank of America | $36.02 +1.7% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $49.00 -> $50.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 1/30/2024 |
PNST Pinstripes | $4.12 +2.7% | 1/30/2024 | Initiated by | Oppenheimer | - | Outperform | $6.00 | Low | View details for Oppenheimer rating of Pinstripes (NYSE:PNST) on 1/30/2024 |
ST Sensata Technologies | $35.78 +0.6% | 1/30/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $50.00 | Low | View details for Oppenheimer rating of Sensata Technologies (NYSE:ST) on 1/30/2024 |
FIVE Five Below | $205.90 +2.1% | 1/30/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | $235.00 -> $200.00 | Low | View details for Oppenheimer rating of Five Below (NASDAQ:FIVE) on 1/30/2024 |
AXP American Express | $220.85 +1.1% | 1/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $208.00 -> $219.00 | Low | View details for Oppenheimer rating of American Express (NYSE:AXP) on 1/29/2024 |
CRBP Corbus Pharmaceuticals | $41.62 -4.7% | 1/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $20.00 -> $51.00 | Low | View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 1/29/2024 |
AI Cracks Open Largest Untapped Energy Reserve on Earth (Ad) This orb represents the largest untapped energy source in the world…
And although this energy resource is unknown by 99% of the public…
It makes gas, coal, oil, wind, hydropower, solar, fusion… ]click here to watch a free presentation where I reveal all the details of this lucrative opportunit |
INTU Intuit | $630.39 +0.8% | 1/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $610.00 -> $678.00 | Low | View details for Oppenheimer rating of Intuit (NASDAQ:INTU) on 1/29/2024 |
RXST RxSight | $46.76 -0.9% | 1/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $54.00 | Low | View details for Oppenheimer rating of RxSight (NASDAQ:RXST) on 1/29/2024 |
BFH Bread Financial | $38.38 +3.2% | 1/26/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $52.00 | Low | View details for Oppenheimer rating of Bread Financial (NYSE:BFH) on 1/26/2024 |
COIN Coinbase Global | $239.62 -1.1% | 1/26/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $160.00 | Low | View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 1/26/2024 |
PYPL PayPal | $64.23 +2.2% | 1/25/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of PayPal (NASDAQ:PYPL) on 1/25/2024 |
VERA Vera Therapeutics | $41.47 -4.1% | 1/25/2024 | Initiated by | Oppenheimer | - | Outperform | $26.00 | Low | View details for Oppenheimer rating of Vera Therapeutics (NASDAQ:VERA) on 1/25/2024 |
INO Inovio Pharmaceuticals | $10.72 -0.1% | 1/25/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $48.00 | Low | View details for Oppenheimer rating of Inovio Pharmaceuticals (NASDAQ:INO) on 1/25/2024 |
NFLX Netflix | $618.39 +2.1% | 1/24/2024 | Target Raised by | Oppenheimer | - | Outperform | $600.00 -> $615.00 | Low | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 1/24/2024 |
FLYW Flywire | $25.78 +0.7% | 1/23/2024 | Initiated by | Oppenheimer | - | Outperform | $25.00 | Low | View details for Oppenheimer rating of Flywire (NASDAQ:FLYW) on 1/23/2024 |
LOW Lowe's Companies | $243.48 -0.5% | 1/22/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Lowe’s Companies (NYSE:LOW) on 1/22/2024 |
HD Home Depot | $371.89 -0.4% | 1/22/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Home Depot (NYSE:HD) on 1/22/2024 |
CWEN Clearway Energy | $21.01 -0.2% | 1/19/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $33.00 -> $37.00 | Low | View details for Oppenheimer rating of Clearway Energy (NYSE:CWEN) on 1/19/2024 |
ORA Ormat Technologies | $63.46 -0.6% | 1/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $84.00 -> $83.00 | Low | View details for Oppenheimer rating of Ormat Technologies (NYSE:ORA) on 1/19/2024 |
WSC WillScot Mobile Mini | $45.05 -1.4% | 1/19/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $57.00 | Low | View details for Oppenheimer rating of WillScot Mobile Mini (NASDAQ:WSC) on 1/19/2024 |
JELD JELD-WEN | $18.44 -0.6% | 1/19/2024 | Initiated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of JELD-WEN (NYSE:JELD) on 1/19/2024 |
FBIN Fortune Brands Innovations | $78.98 -1.4% | 1/19/2024 | Initiated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Fortune Brands Innovations (NYSE:FBIN) on 1/19/2024 |
MAS Masco | $73.88 -0.4% | 1/19/2024 | Initiated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Masco (NYSE:MAS) on 1/19/2024 |
T AT&T | $17.30 +1.5% | 1/19/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $21.00 | Low | View details for Oppenheimer rating of AT&T (NYSE:T) on 1/19/2024 |
ITRI Itron | $87.41 +0.5% | 1/19/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $81.00 | Low | View details for Oppenheimer rating of Itron (NASDAQ:ITRI) on 1/19/2024 |
DOOR Masonite International | $130.74 +0.0% | 1/19/2024 | Initiated by | Oppenheimer | - | Outperform | $115.00 | Low | View details for Oppenheimer rating of Masonite International (NYSE:DOOR) on 1/19/2024 |
BLDR Builders FirstSource | $195.44 0.0% | 1/19/2024 | Initiated by | Oppenheimer | - | Outperform | $220.00 | Low | View details for Oppenheimer rating of Builders FirstSource (NYSE:BLDR) on 1/19/2024 |
NOW ServiceNow | $755.62 +1.6% | 1/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $750.00 -> $800.00 | Low | View details for Oppenheimer rating of ServiceNow (NYSE:NOW) on 1/18/2024 |
UNH UnitedHealth Group | $487.08 -0.8% | 1/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $610.00 | Low | View details for Oppenheimer rating of UnitedHealth Group (NYSE:UNH) on 1/17/2024 |
CHE Chemed | $648.15 +0.2% | 1/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $590.00 -> $625.00 | Low | View details for Oppenheimer rating of Chemed (NYSE:CHE) on 1/17/2024 |
GS The Goldman Sachs Group | $384.37 -0.7% | 1/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $481.00 -> $491.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 1/17/2024 |
HCA HCA Healthcare | $327.18 +1.6% | 1/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $315.00 | Low | View details for Oppenheimer rating of HCA Healthcare (NYSE:HCA) on 1/17/2024 |
HUM Humana | $347.19 -0.3% | 1/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $630.00 | Low | View details for Oppenheimer rating of Humana (NYSE:HUM) on 1/17/2024 |
MS Morgan Stanley | $87.99 -0.4% | 1/17/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $107.00 -> $106.00 | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 1/17/2024 |
ENSG The Ensign Group | $122.19 -0.4% | 1/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $115.00 -> $127.00 | Low | View details for Oppenheimer rating of The Ensign Group (NASDAQ:ENSG) on 1/17/2024 |
PNTG The Pennant Group | $18.95 +3.0% | 1/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $16.00 -> $18.00 | Low | View details for Oppenheimer rating of The Pennant Group (NASDAQ:PNTG) on 1/17/2024 |
ADUS Addus HomeCare | $101.20 +4.6% | 1/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $118.00 | Low | View details for Oppenheimer rating of Addus HomeCare (NASDAQ:ADUS) on 1/17/2024 |
ALB Albemarle | $124.58 +2.0% | 1/17/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $308.00 -> $191.00 | Low | View details for Oppenheimer rating of Albemarle (NYSE:ALB) on 1/17/2024 |
CI The Cigna Group | $352.63 +0.2% | 1/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $360.00 | Low | View details for Oppenheimer rating of The Cigna Group (NYSE:CI) on 1/17/2024 |
USB U.S. Bancorp | $42.48 +1.0% | 1/17/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $63.00 -> $60.00 | Low | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 1/17/2024 |
BAC Bank of America | $36.02 +1.7% | 1/16/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $49.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 1/16/2024 |
C Citigroup | $58.63 +1.8% | 1/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $93.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 1/16/2024 |
JPM JPMorgan Chase & Co. | $192.70 +1.3% | 1/16/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $234.00 -> $232.00 | Low | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 1/16/2024 |
RXST RxSight | $46.76 -0.9% | 1/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $46.00 -> $50.00 | Low | View details for Oppenheimer rating of RxSight (NASDAQ:RXST) on 1/16/2024 |
MCRB Seres Therapeutics | $0.76 -3.8% | 1/16/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $9.00 | Low | View details for Oppenheimer rating of Seres Therapeutics (NASDAQ:MCRB) on 1/16/2024 |
RSG Republic Services | $187.57 +0.7% | 1/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $172.00 -> $182.00 | Low | View details for Oppenheimer rating of Republic Services (NYSE:RSG) on 1/12/2024 |
WCN Waste Connections | $171.72 +0.5% | 1/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $154.00 -> $155.00 | Low | View details for Oppenheimer rating of Waste Connections (NYSE:WCN) on 1/12/2024 |
WM Waste Management | $211.67 +0.5% | 1/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $184.00 -> $188.00 | Low | View details for Oppenheimer rating of Waste Management (NYSE:WM) on 1/12/2024 |
WT WisdomTree | $8.88 -0.6% | 1/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $11.00 | Low | View details for Oppenheimer rating of WisdomTree (NYSE:WT) on 1/12/2024 |
XPO XPO | $122.04 -0.5% | 1/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $90.00 -> $100.00 | Low | View details for Oppenheimer rating of XPO (NYSE:XPO) on 1/12/2024 |
NFLX Netflix | $618.39 +2.1% | 1/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $475.00 -> $600.00 | Low | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 1/12/2024 |
FI Fiserv | $152.16 +1.7% | 1/11/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $168.00 | Low | View details for Oppenheimer rating of Fiserv (NYSE:FI) on 1/11/2024 |
HLNE Hamilton Lane | $105.77 -0.3% | 1/11/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Hamilton Lane (NASDAQ:HLNE) on 1/11/2024 |
BX Blackstone | $123.46 -1.2% | 1/11/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Blackstone (NYSE:BX) on 1/11/2024 |
MA Mastercard | $479.07 +0.7% | 1/11/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $510.00 | Low | View details for Oppenheimer rating of Mastercard (NYSE:MA) on 1/11/2024 |
CLVT Clarivate | $7.21 +2.1% | 1/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $11.00 | Low | View details for Oppenheimer rating of Clarivate (NYSE:CLVT) on 1/8/2024 |
CYBR CyberArk Software | $260.92 +0.7% | 1/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $195.00 -> $260.00 | Low | View details for Oppenheimer rating of CyberArk Software (NASDAQ:CYBR) on 1/8/2024 |
MSCI MSCI | $550.39 +1.0% | 1/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $572.00 -> $601.00 | Low | View details for Oppenheimer rating of MSCI (NYSE:MSCI) on 1/8/2024 |
RXST RxSight | $46.76 -0.9% | 1/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $38.00 -> $46.00 | Low | View details for Oppenheimer rating of RxSight (NASDAQ:RXST) on 1/8/2024 |
SEIC SEI Investments | $68.74 +0.2% | 1/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $71.00 | Low | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 1/8/2024 |
TREE LendingTree | $36.46 -3.9% | 1/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $45.00 | Low | View details for Oppenheimer rating of LendingTree (NASDAQ:TREE) on 1/8/2024 |
COST Costco Wholesale | $731.54 +0.8% | 1/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $675.00 -> $695.00 | Low | View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 1/5/2024 |
CRWD CrowdStrike | $321.06 +1.7% | 1/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $240.00 -> $300.00 | Low | View details for Oppenheimer rating of CrowdStrike (NASDAQ:CRWD) on 1/5/2024 |
DRI Darden Restaurants | $172.87 +0.5% | 1/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $186.00 | Low | View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 1/5/2024 |
DENN Denny's | $8.80 -1.3% | 1/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $13.00 | Low | View details for Oppenheimer rating of Denny’s (NASDAQ:DENN) on 1/5/2024 |
DPZ Domino's Pizza | $442.86 +0.4% | 1/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $450.00 -> $470.00 | Low | View details for Oppenheimer rating of Domino’s Pizza (NYSE:DPZ) on 1/5/2024 |